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ABSTRACT
A mixed outbreak caused by vancomycin-resistant Enterococcus raffinosus and Enterococcus faecium
carrying the vanA gene was analysed. The outbreak occurred in a large hospital in Poland and affected
27 patients, most of whom were colonised, in three wards, including the haematology unit. The
E. raffinosus isolates had a high-level multiresistant phenotype and were initially misidentified as
Enterococcus avium; their unambiguous identification was provided by multilocus sequence analysis. The
molecular investigation demonstrated the clonal character of the E. raffinosus outbreak and the
polyclonal structure of the E. faecium isolates. All of the isolates carried the same Tn1546-like element
containing an IS1251-like insertion sequence, located on a c. 50-kb conjugative plasmid. One of the
E. faecium clones, found previously to be endemic in the hospital, was probably the source of the
plasmid. The results of the study suggest that difficulties in identification may have led to an
underestimate of the importance of E. raffinosus in vancomycin-resistant enterococci (VRE) control
strategies.
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INTRODUCTION
Outbreaks of vancomycin-resistant enterococci
(VRE) usually occur in hospital settings, e.g.,
haematology wards or clinics, with severely
debilitated, immunocompromised patients [1–3].
In some countries, e.g., the USA, the UK and Italy,
outbreaks are relatively frequent and often result
from the clonal spread of multiresistant VRE
strains [2]. VRE outbreaks are mostly caused by
two predominant enterococcal species, namely
Enterococcus faecalis and Enterococcus faecium,
whereas vancomycin-resistant organisms of other
species appear only sporadically [1,2,4,5]. Thus,
Enterococcus raffinosus is usually represented
by few isolates in VRE survey studies or collec-
tions [6–11]. To our knowledge, the only descrip-
tion of clonal spread of vancomycin-resistant
E. raffinosus concerned a US hospital between
December 1995 and February 1996, where it
affected four patients and was detected post
factum [12]. Interestingly, the isolates of E. raffino-
sus involved were initially misidentified as
Enterococcus avium.
Since 1997, haematology units in Poland have
experienced several outbreaks of infection involv-
ing VRE, caused mostly by E. faecium with either
VanA [13] or VanB [14,15] phenotypes. A variety
of epidemiological phenomena have been identi-
fied, e.g., the parallel dissemination of several
clones, horizontal transfer of van genes, and the
multiplication and modification of van gene
clusters, occasionally with profound conse-
quences for the resistance phenotype. Despite
the introduction of control measures, VRE still
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pose a problem in some Polish haematology units.
In one such unit, with a previous history of VRE
outbreaks [14], the control measures instituted
included routine screening of patients for VRE
carriage, combined with isolation of both colo-
nised and infected individuals. In March 2005, a
single patient appeared to be colonised by VRE
with the VanA phenotype, with the responsible
organism being identified by the hospital labor-
atory as E. avium, with subsequent re-identifica-
tion as E. raffinosus. Soon after, similar isolates
were recovered from 19 other patients, often
accompanied by isolates of E. faecium that also
exhibited the VanA phenotype. The aim of the
present study was to characterise this new VRE-
associated threat in the hospital setting.
MATERIALS AND METHODS
The VRE outbreak and associated clinical isolates
The first Enterococcus isolate with the VanA phenotype, which
had an unusual colonial morphology on Columbia agar
supplemented with sheep blood, was recovered from an
asymptomatic patient in the haematology ward of the Univer-
sity Hospital, Krako´w, Poland, on 16 March 2005. This isolate
was cultured during VRE screening (rectal swabs) performed
routinely every 2–3 weeks in this unit. The hospital micro-
biology laboratory identified the isolate as E. avium. After a
further 3 weeks, similar isolates were obtained from a patient
with urinary tract infection and from two new carriers in the
haematology ward, as well as from three patients with various
infections in the surgery ward. Both the colonised and the
infected patients were isolated and the hospital-wide monit-
oring programme was intensified, resulting in further VRE
identifications, including isolates from patients in the neph-
rology ward. By the beginning of June, 20 patients in three
wards (haematology, 12 patients; surgery, six patients; neph-
rology, two patients) were presumed to harbour VanA+
E. avium. In seven cases, E. avium was accompanied by VanA+
E. faecium. Additionally, E. faecium was recovered as the only
VRE from seven patients in the haematology and surgery
wards. In total, 34 VRE isolates (20 E. avium and 14 E. faecium)
were collected and sent to the National Medicines Institute,
Warsaw, Poland, for re-identification and further analysis
(Table 1). With the exception of two E. avium isolates, cultured
from the urine and rectal swabs of the same patient, all other
E. avium and E. faecium isolates were derived from different
patients.
Identification of VRE isolates
The isolates were identified as enterococci according to the
following criteria: Gram-positive, catalase-negative cocci;
growth on bile-aesculin agar, in NaCl 6.5% w ⁄v broth and in
pH 9.6 broth; and hydrolysis of L-pyrrolydonyl-b-naphthyla-
mide (MurexPYR; MurexDiagnostics, Dartford, UK). Identifi-
cation to the species level was performed in the hospital
laboratory with the RAPID32 STREP test (bioMe´rieux, Char-
bonnieres-les-Bains, France). Phenotypic identification in the
National Medicines Institute was carried out with the API-20
Table 1. Selected clinical data and characteristics of the enterococcal isolates included in the study
Speciesa
(no. of isolates) Sourceb
Date of isolation
(month ⁄ year);
wardc
PFGE ⁄ Tn1546
hybridisationd
REAP ⁄ Tn1546
hybridisatione Transferf
Antimicrobial susceptibility
PEN AMP GEN STR VAN TEI CHL TET CIP RIF
ER (14) C; NI (drain, wound);
I (bile, urine)
03–06 ⁄ 2005;
H or S
a1 ⁄H1 p1–p4 ⁄h1 +2,3 R R R R R R R S, R R R
ER C 04 ⁄ 2005; H a2 ⁄H1 p3 ⁄h1 +2 R R R R R R R R R I
ER I (bile) 05 ⁄ 2005; S a3 ⁄H2 p3 ⁄h1 +2 R R S R R R R R R R
ER C 04 ⁄ 2005; H a4 ⁄H2 p3 ⁄h1 +2 R R R R R R R R R R
ER C 05 ⁄ 2005; Ng a5 ⁄H1 p3 ⁄h1 +2,3 R R R R R R R R R R
ER (2) C 05 ⁄ 2005; H a6 ⁄H1 p3 ⁄h1 +3 R R R R R R R R R R
EFm (4) C, NI (drain) 04 ⁄ 2005;
H or S
A1 ⁄H1 p10, p12,
p14 ⁄h1
+1,2,3, +2,3 R R R R R R S, I, R S R S, I, R
EFm C 04 ⁄ 2005; H A2 ⁄H3 p10 ⁄h1 +2,3 R R R R R R I S R S
EFm C 04 ⁄ 2005; H A3 ⁄H1 p6 ⁄h1 +3 R R R R R R I S R I
EFm C 05 ⁄ 2005; H B ⁄H1 p13 ⁄h1 +1,2,3 R R S R R R I S R I
EFm C 05 ⁄ 2005; H C ⁄H1 p5 ⁄h1 +1,2,3 R R R R R R R R R I
EFm (2) C; NI (wound) 05–06 ⁄ 2005; H D ⁄H1 p13 ⁄h1 +2, +2,3 R R R R R R I R R R
EFm C 05 ⁄ 2005; H E ⁄H4 p11 ⁄h1 +1,2,3 R R S R R R I S R S
EFm C 05 ⁄ 2005; S F ⁄H1 p8 ⁄h1 +1,2,3 R R R R R R R R R S
EFm (2) C; NI (wound) 06 ⁄ 2005; S G ⁄H5 p7, p9 ⁄h2 +2, +3 R R R R R R R R R S, R
aER, Enterococcus raffinosus; EFm, Enterococcus faecium.
bC, carriage (rectal swabs); I, infection; NI, colonisation (absence of symptoms of infection).
cH, haematology; N, nephrology; S, surgery.
dPulsed-field gel electrophoresis (PFGE) types for E. faecium are designated by capital letters and those for E. raffinosus by lower-case letters; designations H1–H5 refer to
patterns of hybridisation of the Tn1546 probe to the SmaI-digested and PFGE-separated genomic DNA of the isolates (PFGE subtypes were determined for representative
isolates only).
eREAP, restriction endonuclease analysis of plasmids; designations p1–p13 refer to Bsp120I restriction patterns of plasmid DNA; designations h1 and h2 refer to hybridisation
patterns of the Tn1546 probe to plasmids digested with restriction enzymes.
fIsolates that produced transconjugants (+) are indicated. Recipients were: 1Enterococcus faecalis FA2-2; 2E. faecium 64 ⁄ 3; 3E. faecium BM4105RF. For E. raffinosus PFGE subtypes
a1 and a6, conjugation experiments were performed for representative isolates only.
gOne additional patient in the nephrology ward who was infected with ‘E. avium’ (source, urine) was noted in 05 ⁄ 2005 by the epidemiological service of the hospital, but the
isolate was not sent to the National Medicines Institute.
PEN, penicillin; AMP, ampicillin; GEN, gentamicin; STR, streptomycin; VAN, vancomycin; TEI, teicoplanin; CHL, chloramphenicol; TET, tetracycline; CIP, ciprofloxacin; RIF,
rifampicin; R, resistant; I, intermediate; S, susceptible (for gentamicin and streptomycin, the categories refer to high concentrations of these compounds).
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STREP test (bioMe´rieux), supplemented by tests for potassium
tellurite reduction, motility and pigment production [16], and
with the AST-P534 panel card in the VITEK 2 Compact
Version system (bioMe´rieux, Durham, NC, USA). DNA-based
species identification was performed using multilocus
sequence analysis (MLSA) of the rpoA and pheS genes, as
described by Naser et al. [17]. E. avium ATCC 14025, E. faecalis
ATCC 29212, E. faecium BM4147 [18] and Enterococcus gallina-
rum BM4174 [19] were used as control strains.
Antimicrobial susceptibility testing
MICs of antimicrobial agents were determined by the agar
dilution method according to CLSI guidelines [20]. The
following agents were tested: penicillin, ampicillin, gentami-
cin, streptomycin, tetracycline, rifampicin and chlorampheni-
col (Polfa Tarchomin, Warsaw, Poland); vancomycin (Lilly,
Indianapolis, IN, USA); teicoplanin (Marion Merrell Dow,
Denham, UK); and ciprofloxacin (Bayer, Wuppertal, Ger-
many). Susceptibility to linezolid was tested using Etests (AB
Biodisk, Solna, Sweden). E. faecalis ATCC 29212, Staphylococcus
aureus ATCC 29213, E. faecium BM4147 (VanA) and E. faecium
BM4147-1 (vancomycin-susceptible) reference strains [18] were
used as controls.
Resistance transfer
Transfer of vancomycin resistance was investigated using the
filter-mating procedure, with E. faecalis FA2-2, E. faecium 64 ⁄ 3
and E. faecium BM4105RF (resistant to rifampicin and fusidic
acid) as recipients [21]. Transconjugants were selected on
brain–heart infusion agar (Oxoid, Basingstoke, UK) containing
rifampicin 64 mg ⁄L, fusidic acid 64 mg ⁄L (Leo Pharmaceutical
Products, Ballerup, Denmark) and vancomycin 32 mg ⁄L in the
case of donor isolates with rifampicin MICs £8 mg ⁄L, and on
agar containing fusidic acid and vancomycin in the case of
donors with rifampicin MICs ‡32 mg ⁄L. Conjugation was
verified by comparative pulsed-field gel electrophoresis
(PFGE) analysis of transconjugants against donor and recipient
strains, and by detection of the vanA gene by PCR in the
transconjugants (see below).
PFGE typing
Genomic DNA of the isolates, embedded in agarose 0.75%
w ⁄v plugs (InCert Agarose; FMC Bioproducts, Rockland, ME,
USA), was digested with SmaI (Fermentas, Vilnius, Lithuania)
and separated in Pulsed Field-Certified agarose (Bio-Rad,
Hercules, CA, USA) in a CHEF DR III system (Bio-Rad). DNA
was purified as described by Clark et al. [6]. PFGE was
performed using the same run conditions for both species
(voltage 6 V; pulse time 1–25 s; run time 22 h). PFGE patterns
were analysed according to the criteria of Tenover et al. [22].
E. avium ATCC 14025 and E. faecium BM4147 [18] were used as
control strains.
Detection of the vanA gene
Total DNA was purified from the isolates using the Genomic
DNA Prep Plus kit (A&A Biotechnology, Gdan´sk, Poland). The
vanA gene was detected using specific PCR primers as
described by Clark et al. [6]. DNA isolated from E. faecium
BM4147 [18] was used as a positive control.
Amplification of Tn1546-like transposons and vanRSHAX
regions by long-PCR (L-PCR) and subsequent restriction
fragment length polymorphism analysis
Tn1546-like elements were amplified from total DNA of the
isolates using the Expand Long Template PCR System
(Roche Diagnostics, Mannheim, Germany). Subsequently,
these amplicons were used as templates in L-PCR of the
vanRSHAX regions. Both PCRs were performed as
described by Palepou et al. [23]. The L-PCR products
containing Tn1546-like elements were digested with Bsu15I
(an isoschizomer of ClaI; Fermentas) and the vanRSHAX
amplicons were digested with DdeI (Promega, Madison, WI,
USA) [23]. DNA from E. faecium BM4147 [18] was used as a
control.
Sequencing of the vanS–vanH intergenic region
The vanS–vanH intergenic region was amplified by PCR using
a forward primer annealing to the vanS gene (5¢-AA-
TTATTGTTCAGCATGGAGGGCAG) and a reverse primer
annealing to the vanH gene (5¢-TTTGGCGTTGGATTCCGA-
CAC). PCR products were purified with the QIAquick PCR
Purification kit (Qiagen, Hilden, Germany) and were then
partially sequenced using the same primers, and an ABI
Prism 310 sequencer (Applied Biosystems, Foster City, CA,
USA).
Genetic location of Tn1546
The SmaI-digested and the undigested total DNA of the
isolates were separated by PFGE (as described above), blotted
on Hybond-N membranes (Amersham Pharmacia Biotech,
Little Chalfont, UK), and hybridised with the Tn1546 probe,
using the ECL Random-Prime labelling and detection system
(Amersham Pharmacia Biotech). The probe was obtained by
labelling the L-PCR amplicon of the entire Tn1546 element
from E. faecium BM4147 [18]. Total DNA of E. faecium BM4147
[18] was used as a positive control in the hybridisation
experiment. Plasmid DNA was purified from bacterial sphero-
plasts using a Plasmid Midi Kit (Qiagen) as described
previously [15]. DNA preparations were digested separately
with Bsp120I, EcoRI and Bsu15I (Fermentas), electrophoresed in
agarose 1% w ⁄v gels, blotted and then hybridised with the
Tn1546 probe.
RESULTS
Species identification
The 20 enterococcal isolates classified as
E. avium by the hospital laboratory were subjec-
ted to several identification procedures. The
classical protocol utilising the API-20 STREP
test (bioMe´rieux) and the scheme of Facklam
and Collins [16] confirmed the initial identifica-
tion as E. avium. However, fundamental differ-
ences in the PFGE patterns of the isolates, when
compared with the E. avium ATCC 14025 refer-
ence strain (Fig. 1) [12], and the resistance of the
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isolates to penicillins, which is uncommon in
E. avium [24], prompted a re-identification. The
VITEK 2 Compact Version system identified the
isolates as E. raffinosus with a rank of ‘excellent’
or ‘very good’ according to the expert pro-
gramme. Unambiguous identification was
achieved with the MLSA approach [17] using
a representative isolate, which revealed 100%
identity with the pheS and rpoA genes of
E. raffinosus. In the case of the 14 E. faecium
isolates, identification by the classical procedure
and the VITEK 2 system was unequivocal.
Antimicrobial susceptibility testing
The susceptibility categories are presented in
Table 1. All of the E. raffinosus and E. faecium
isolates were resistant to penicillin and ampicillin
(MICs 16 - >128 mg ⁄L), glycopeptides (vanco-
mycin MICs 128–1024 mg ⁄L; teicoplanin MICs
32–128 mg ⁄L) and ciprofloxacin (MICs 16 - >64
mg ⁄L). High-level resistance was uniform in
the case of streptomycin (MICs ‡2048 mg ⁄L),
whereas one isolate of E. raffinosus and two of
E. faecium remained susceptible to high con-
centrations of gentamicin (MICs 8–16 mg ⁄L).
Susceptibility to tetracycline and rifampicin
differentiated the two species, with almost all of
the E. raffinosus isolates being non-susceptible and
the majority of E. faecium isolates being suscept-
ible or intermediately-susceptible to these com-
pounds. All isolates were susceptible to linezolid.
PFGE typing
The results of the PFGE analysis are presented in
Table 1. Fig. 1 shows the PFGE patterns of 11
selected E. raffinosus isolates. All the E. raffinosus
isolates belonged to a single type, designated ‘a’,
which was divided into several subtypes (a1–a6)
[22]. The most common of these was PFGE
subtype a1 (15 isolates), which was identified in
isolates from the haematology and surgery
wards. In contrast, seven PFGE types (A–G)
were distinguished among the E. faecium isolates,
with the predominant type A represented by six
isolates from the haematology and surgery
wards. These isolates could be differentiated
into subtypes A1–A3. Two indistinguishable
E. faecium isolates from the haematology ward
were classified into type D, and two isolates
from the surgery ward into type G. The remain-
ing types were unique.
Detection of the vanA gene
A fragment of c. 1030 bp, corresponding to the
expected size of the vanA gene, was amplified
from all of the enterococcal isolates (data not
shown).
Resistance transfer
Each of the six E. raffinosus isolates tested,
representing each of the PFGE subtypes, as well
as all the E. faecium isolates, transferred the
glycopeptide resistance determinants to at least
one of the recipient strains (Table 1). The vanA
gene was detected in all the transconjugants
obtained, which had a pulsotype similar to the
respective recipients and distinguishable from
the donor isolates (data not shown). In gen-
eral, the frequency of transfer observed for
E. raffinosus was three to five orders of magni-
tude lower than that observed for E. faecium.
Five E. faecium isolates, but none of the E. raffi-
nosus isolates, yielded transconjugants with
E. faecalis FA2-2.
Fig. 1. SmaI pulsed-field gel electrophoresis patterns of
selected Enterococcus raffinosus isolates. Lanes: M, k DNA
Ladder (New England Biolabs, Beverly, MA, USA); 1,
isolate 2229 ⁄ 05 (PFGE subtype a2); 2, isolate 2225 ⁄ 05 (a3);
3, isolate 2226 ⁄ 05 (a1); 4, isolate 2223 ⁄ 05 (a1); 5, isolate
2209 ⁄ 05 (a1); 6, isolate 2215 ⁄ 05 (a1); 7, isolate 2217 ⁄ 05 (a6);
8, isolate 2205 ⁄ 05 (a4); 9, isolate 2229 ⁄ 05 (a5); 10, isolate
2220 ⁄ 05 (a6); 11, isolate 2208 ⁄ 05 (a1); and 12, Enterococcus
avium ATCC 14025.
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Amplification of Tn1546-like transposons and
vanRSHAX regions by L-PCR and subsequent
restriction fragment length polymorphism
analysis
The Tn1546-like transposon harbouring the vanA
gene was amplified from all E. raffinosus and
E. faecium isolates, although with remarkably
lower efficiency than from the E. faecium
BM4147 control strain (data not shown). Restric-
tion analysis with Bsu15I (ClaI) revealed a uni-
form DNA pattern (Fig. 2), which included two
bands of c. 2.5 and 2.0 kb that were common to
the original Tn1546 variant from BM4147 [18], and
an additional band of c. 4.5 kb and a double (or
triple) band of c. 500 bp.
The vanRSHAX gene cluster was amplified
from each of the outbreak isolates, and was found
to be significantly larger in size than that present
in BM4147 [18], indicating that a DNA insertion
must have occurred inside the cluster.
Sequence of the vanS–vanH intergenic region
Differences in restriction patterns between the
vanRSHAX polymorph and E. faecium BM4147
[18] suggested that the DNA insertion had prob-
ably occurred in the vanS–vanH intergenic region.
This region was amplified from representative
isolates of E. raffinosus and E. faecium, and was
then subjected to partial sequence analysis. The
size of the PCR products indicated that the
insertion was c. 1.5 kb in size, and DNA sequenc-
ing revealed the presence of an IS1251-like ele-
ment (c. 500 bp from the vanS side and c. 100 bp
from the vanH side). The element was located at
the same position and in the same orientation as
that found in Tn1546-like transposons from the
USA [25], Norway and Ireland [26] and Brazil
[27], and the sequence fragments were identical to
those described by Simonsen et al. [26] (GenBank
accession number AF148130) and Camargo et al.
[27] (AY560917).
Genetic location of Tn1546
The Tn1546 probe was used to detect glycopep-
tide resistance determinants in SmaI-digested
genomic DNA of representative isolates. Among
seven E. raffinosus isolates analysed, there were
two different PFGE hybridisation patterns, H1
and H2 (Table 1), each consisting of a single DNA
band migrating between the 48.5-kb and 97-kb
bands of the k ladder DNA molecular size
marker. For almost all of the E. raffinosus PFGE
subtypes, the H1-specific band migrated slightly
slower than that of the H2 pattern, which was
observed in an isolate with PFGE subtype a3. The
hybridising bands were in non-equimolar pro-
portions to other bands, which suggested a
possible plasmid association. This hypothesis
was confirmed by PFGE analysis of undigested
total DNA from representative isolates belonging
to PFGE subtypes a1 and a2. The hybridisation
signals were identified at the same positions in
(a)
(b)
(c)
(d)
Fig. 2. (a) Schematic representation of the structure of
transposon Tn1546 from Enterococcus faecium BM4147 [18].
(b) The long-PCR (L-PCR) amplicon of Tn1546, obtained as
proposed by Palepou et al. [23], used in the restriction
fragment length polymorphism (RFLP) analysis with the
Bsu15I (ClaI) restriction enzyme and as a probe in hybrid-
isation studies; the distribution of ClaI restriction sites is
indicated by vertical strokes. (c) The L-PCR amplicon of
the vanRSHAX region, obtained according to Palepou et al.
[23], used in the RFLP analysis with DdeI (location of DdeI
restriction sites is indicated). (d) Bsu15I (ClaI) polymorph
VI of the Tn1546-like transposon and DdeI polymorph II of
the vanRSHAX gene cluster. Lanes: M1, Gene Ruler 100-bp
DNA Ladder Plus (Fermentas, Vilnius, Lithuania); 1,
Bsu15I (ClaI) digest of Tn1546 of E. faecium BM4147 [18];
2, Bsu15I (ClaI) polymorph VI of the Tn1546-like transpo-
son; 3, DdeI digest of the vanRSHAX gene cluster of
E. faecium BM4147 [18]; 4, DdeI polymorph II of the
vanRSHAX gene cluster; and M2, Gene Ruler 100-bp
DNA Ladder (Fermentas).
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the gel as were observed with SmaI-digested
DNA, which indicated the absence of an SmaI
restriction site in the plasmid(s) carrying the vanA
cluster (results not shown).
The H1 pattern of hybridisation was most
frequent among the nine E. faecium isolates ana-
lysed, which represented all of the PFGE types
and subtypes identified in the study (Table 1).
Some isolates were characterised by single bands
of other sizes (PFGE subtype A2, pattern H3; type
E, pattern H4). The isolate belonging to PFGE
type G yielded a specific pattern, designated H5,
with three hybridising bands, one between 194 kb
and 242.5 kb, one just above 242.5 kb, and one
below the 339.5 kb band of the k DNA ladder
(results not shown).
Characterisation of plasmids carrying Tn1546
Plasmid DNA from each of the outbreak isolates
was purified and digested with Bsp120I. Highly
diverse restriction patterns were observed, four in
E. raffinosus isolates and ten in E. faecium isolates
(Table 1), indicating the presence of multiple
plasmids in various combinations in particular
groups of the isolates. However, when these
patterns were hybridised with the Tn1546 probe,
the result was almost uniform, showing one band
of high molecular size (>10 kb), designated pat-
tern h1 (Table 1). Only two E. faecium isolates
(PFGE type G) yielded a smaller band (pattern
h2). The study was continued using plasmid
DNA from the isolates and their transconjugants,
which was digested with Bsu15I (ClaI) and EcoRI
separately. The results obtained were similar,
with both enzymes yielding sets of identical
hybridisation patterns for all but the two E. fae-
cium isolates of PFGE type G (results not shown).
As shown in Fig. 3, the transconjugant of
E. faecium isolate 2227 ⁄ 05 most probably har-
boured a single plasmid molecule of c. 50 kb,
which yielded 16 bands following digestion with
EcoRI (the plasmid size was calculated by calib-
rating the size of the EcoRI restriction fragments).
DNA hybridisation revealed that three of these
bands encompassed the Tn1546-like element.
DISCUSSION
The aim of this work was to investigate the genetic
background of a VRE outbreak in a large medical
centre in Poland, in which outbreaks of E. faecium
or E. faecalis strains with the VanA or VanB
phenotypes have already been reported [14]. The
number of patients affected (n = 27) was remark-
ably high, but most of the VRE isolates were
recovered from the faeces of colonised patients.
One of the most distinctive aspects of the outbreak
was the predominance of a single E. raffinosus
clone. Using classical methods, isolates of this
clone were initially identified as E. avium; how-
ever, the VITEK 2 system and the MLSA molecu-
lar approach [17] both classified the isolates
unequivocally as E. raffinosus. Since E. avium has
been associated more often with human infection,
and has been reported to be vancomycin-resistant
more frequently than has E. raffinosus [28–33],
there was a possibility of misidentification of
these two species. Wilke et al. [12], reported that
six of eight cases of bacteraemia identified by the
VITEK system as being caused by E. avium were
Fig. 3. EcoRI restriction pattern of the c. 50-kb plasmid
carrying the Tn1546-like element, showing the hybridisa-
tion pattern with the Tn1546 probe. Lanes: M, Gene Ruler
DNA Ladder Mix (Fermentas, Vilnius, Lithuania); 1,
plasmid DNA isolated from a transconjugant of Enterococ-
cus faecium 2227 ⁄ 05 digested with EcoRI (plasmid c. 50 kb);
and 2, hybridisation of the Tn1546 probe to the fragments
of the c. 50-kb plasmid shown in lane 1.
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actually caused by E. raffinosus. Interestingly, the
re-identification made use of conventional meth-
ods [16], which, in the context of the present
experience, underlines the significance of MLSA.
As mentioned previously, the study by Wilke et al.
[12] is probably the only report of VanA+ E. raff-
inosus clonal spread to date; however, since these
isolates were collected as part of a surveillance
programme [7], the description was fragmentary
[12].
The results obtained in the present study
indicate the occurrence of an outbreak caused by
a single strain of E. raffinosus, in which all isolates
belonged to a single PFGE type with almost
uniform resistance patterns and levels. Although
a polyclonal population of E. faecium isolates was
observed, pulsotype A was predominant. The
same Tn1546-like transposon was observed in the
other enterococcal isolates studied, suggesting
that dissemination among different species and
clones had occurred.
The Tn1546-like transposon contained the
IS1251-like element inside the vanS–vanH inter-
genic region. Comparative restriction analysis
with the original Tn1546 element [18] also indi-
cated rearrangements in the 5¢ region (orf1 and
orf2), although these were not essential in resist-
ance expression. The positive L-PCR with a
primer that targeted the Tn1546 inverted repeats
(IRs) [23] demonstrated that this polymorph did
indeed contain the IRs; however, the low
efficiency of the L-PCR suggested that these (most
probably IR-L) were also distorted. It is very
likely that this polymorph is related, or even
identical, to the IS1251-containing Tn1546-like
elements originally found in the USA [25] and
later observed in other countries [26,27], which
thereby provides evidence for their further dis-
semination. It should be emphasised that insta-
bility of Tn1546-like transposons has often been
reported and attributed to changes within the
orf1–orf2 region and ⁄ or the presence of IS
elements [23,25,26,34–37].
The present hypothesis that horizontal spread
of the Tn1546-like transposon among clones had
occurred was supported by hybridisation of
Tn1546 to several putative plasmids. One of
these was predominant (hybridisation pattern
H1) and was further characterised as a conjuga-
tive molecule of c. 50 kb. It is possible that
plasmids of other sizes (patterns H2–H4) were
derivatives of H1, as indicated by the uniform
hybridisation of Tn1546 with plasmids H1–H4
that had been purified and cut with restriction
enzymes (hybridisation pattern h1). Two E. fae-
cium isolates belonging to PFGE type G differed
significantly in terms of the location of the
Tn1546-like element, which was found to reside
in a different plasmid context (pattern H5), either
in a single molecule observed in three confor-
mations according to PFGE, or in two or three
different plasmids. The H5-specific plasmid(s)
might have acquired the Tn1546-like element
from H1; indeed, one of the E. faecium isolates
was recovered from the same site (wound) as
one of the E. raffinosus isolates. Previous studies
have shown that the content and structure of
plasmids in enterococcal strains can change
quickly, even during ongoing clonal outbreaks
[13–15].
Most probably, the E. faecium clone defined as
PFGE type A acted as a reservoir for the
glycopeptide resistance determinant found in
the isolates in this study. During 2002–2003, this
clone had been responsible for a successfully
controlled outbreak in the haematology ward.
However, even if clone A had not been isolated
from new haematology patients during 2004, it
could have persisted in other wards that were
not covered by the strict VRE control system.
The first E. faecium isolate belonging to PFGE
type A was identified during the new outbreak
at almost the same time as the first E. raffinosus
isolate, and clone A predominated among
E. faecium isolates.
The outbreak described in this study occurred
despite the extensive efforts of the staff of a
medical centre experienced in controlling VRE.
As with similar outbreaks reported to date, the
outbreak had a very complex genetic back-
ground. This study has clearly demonstrated
that some rarely encountered Enterococcus spp.,
which often fail to be identified by widely used
identification systems, may become important
reservoirs of van genes and contribute signifi-
cantly to the dissemination of resistance. Accord-
ingly, certain widely held beliefs concerning
these organisms, including E. raffinosus, e.g., that
‘the majority of isolates do not transmit vanco-
mycin resistance genes or proliferate’ [38], may
come into question in the near future, and
E. raffinosus should be taken into consideration
when devising control procedures for enterococcal
infections.
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